Selected research
Industry Research
Methylation Analysis Industry Research Report 2026
Market perspective
The global Methylation Analysis market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Methylation Analysis market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Methylation Analysis market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Methylation Analysis market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Methylation Analysis include Berry Genomics, Illumina Inc., Diagenode, Novogene, Qiagen N.V., Oebiotech, RiboBio, Merck KGaA and BGI, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Methylation Analysis market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Methylation Analysis.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Methylation Analysis Market by Company
Berry Genomics
Illumina Inc.
Diagenode
Novogene
Qiagen N.V.
Oebiotech
RiboBio
Merck KGaA
BGI
Seqhealth
Zymo Research Corporation
Epigentek
Promega Corporation
CD Genomics
BioCat GmbH
Methylation Analysis Segment by Type
DNA Methylation Sequencing
RNA Methylation Sequencing
Methylation Analysis Segment by Application
Clinical
Laboratory
Others
Methylation Analysis Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Methylation Analysis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Methylation Analysis and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Methylation Analysis.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Methylation Analysis companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- DNA Methylation Sequencing
- RNA Methylation Sequencing
Applications
- Clinical
- Laboratory
- Others
Companies covered
- Berry Genomics
- Illumina Inc.
- Diagenode
- Novogene
- Qiagen N.V.
- Oebiotech
- RiboBio
- Merck KGaA
- BGI
- Seqhealth
- Zymo Research Corporation
- Epigentek
- Promega Corporation
- CD Genomics
- BioCat GmbH
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Methylation Analysis by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 DNA Methylation Sequencing
- 2.2.3 RNA Methylation Sequencing
- 2.3 Methylation Analysis by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Clinical
- 2.3.3 Laboratory
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Methylation Analysis Breakdown Data by Type
- 3.1 Global Methylation Analysis Historic Market Size by Type (2021-2026)
- 3.2 Global Methylation Analysis Forecasted Market Size by Type (2027-2032)
4 Methylation Analysis Breakdown Data by Application
- 4.1 Global Methylation Analysis Historic Market Size by Application (2021-2026)
- 4.2 Global Methylation Analysis Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Methylation Analysis Market Perspective (2021-2032)
- 5.2 Global Methylation Analysis Growth Trends by Region
- 5.2.1 Global Methylation Analysis Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Methylation Analysis Historic Market Size by Region (2021-2026)
- 5.2.3 Methylation Analysis Forecasted Market Size by Region (2027-2032)
- 5.3 Methylation Analysis Market Dynamics
- 5.3.1 Methylation Analysis Industry Trends
- 5.3.2 Methylation Analysis Market Drivers
- 5.3.3 Methylation Analysis Market Challenges
- 5.3.4 Methylation Analysis Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Methylation Analysis Players by Revenue
- 6.1.1 Global Top Methylation Analysis Players by Revenue (2021-2026)
- 6.1.2 Global Methylation Analysis Revenue Market Share by Players (2021-2026)
- 6.2 Global Methylation Analysis Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Methylation Analysis Head Office and Area Served
- 6.4 Global Methylation Analysis Players, Product Type & Application
- 6.5 Global Methylation Analysis Manufacturers Established Date
- 6.6 Global Methylation Analysis Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Methylation Analysis Market Size (2021-2032)
- 7.2 North America Methylation Analysis Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Methylation Analysis Market Size by Country (2021-2026)
- 7.4 North America Methylation Analysis Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Methylation Analysis Market Size (2021-2032)
- 8.2 Europe Methylation Analysis Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Methylation Analysis Market Size by Country (2021-2026)
- 8.4 Europe Methylation Analysis Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Methylation Analysis Market Size (2021-2032)
- 9.2 Asia-Pacific Methylation Analysis Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Methylation Analysis Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Methylation Analysis Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Methylation Analysis Market Size (2021-2032)
- 10.2 South America Methylation Analysis Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Methylation Analysis Market Size by Country (2021-2026)
- 10.4 South America Methylation Analysis Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Methylation Analysis Market Size (2021-2032)
- 11.2 Middle East & Africa Methylation Analysis Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Methylation Analysis Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Methylation Analysis Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Berry Genomics
- 12.1.1 Berry Genomics Company Information
- 12.1.2 Berry Genomics Business Overview
- 12.1.3 Berry Genomics Revenue in Methylation Analysis Business (2021-2026)
- 12.1.4 Berry Genomics Methylation Analysis Product Portfolio
- 12.1.5 Berry Genomics Recent Developments
- 12.2 Illumina Inc.
- 12.2.1 Illumina Inc. Company Information
- 12.2.2 Illumina Inc. Business Overview
- 12.2.3 Illumina Inc. Revenue in Methylation Analysis Business (2021-2026)
- 12.2.4 Illumina Inc. Methylation Analysis Product Portfolio
- 12.2.5 Illumina Inc. Recent Developments
- 12.3 Diagenode
- 12.3.1 Diagenode Company Information
- 12.3.2 Diagenode Business Overview
- 12.3.3 Diagenode Revenue in Methylation Analysis Business (2021-2026)
- 12.3.4 Diagenode Methylation Analysis Product Portfolio
- 12.3.5 Diagenode Recent Developments
- 12.4 Novogene
- 12.4.1 Novogene Company Information
- 12.4.2 Novogene Business Overview
- 12.4.3 Novogene Revenue in Methylation Analysis Business (2021-2026)
- 12.4.4 Novogene Methylation Analysis Product Portfolio
- 12.4.5 Novogene Recent Developments
- 12.5 Qiagen N.V.
- 12.5.1 Qiagen N.V. Company Information
- 12.5.2 Qiagen N.V. Business Overview
- 12.5.3 Qiagen N.V. Revenue in Methylation Analysis Business (2021-2026)
- 12.5.4 Qiagen N.V. Methylation Analysis Product Portfolio
- 12.5.5 Qiagen N.V. Recent Developments
- 12.6 Oebiotech
- 12.6.1 Oebiotech Company Information
- 12.6.2 Oebiotech Business Overview
- 12.6.3 Oebiotech Revenue in Methylation Analysis Business (2021-2026)
- 12.6.4 Oebiotech Methylation Analysis Product Portfolio
- 12.6.5 Oebiotech Recent Developments
- 12.7 RiboBio
- 12.7.1 RiboBio Company Information
- 12.7.2 RiboBio Business Overview
- 12.7.3 RiboBio Revenue in Methylation Analysis Business (2021-2026)
- 12.7.4 RiboBio Methylation Analysis Product Portfolio
- 12.7.5 RiboBio Recent Developments
- 12.8 Merck KGaA
- 12.8.1 Merck KGaA Company Information
- 12.8.2 Merck KGaA Business Overview
- 12.8.3 Merck KGaA Revenue in Methylation Analysis Business (2021-2026)
- 12.8.4 Merck KGaA Methylation Analysis Product Portfolio
- 12.8.5 Merck KGaA Recent Developments
- 12.9 BGI
- 12.9.1 BGI Company Information
- 12.9.2 BGI Business Overview
- 12.9.3 BGI Revenue in Methylation Analysis Business (2021-2026)
- 12.9.4 BGI Methylation Analysis Product Portfolio
- 12.9.5 BGI Recent Developments
- 12.10 Seqhealth
- 12.10.1 Seqhealth Company Information
- 12.10.2 Seqhealth Business Overview
- 12.10.3 Seqhealth Revenue in Methylation Analysis Business (2021-2026)
- 12.10.4 Seqhealth Methylation Analysis Product Portfolio
- 12.10.5 Seqhealth Recent Developments
- 12.11 Zymo Research Corporation
- 12.11.1 Zymo Research Corporation Company Information
- 12.11.2 Zymo Research Corporation Business Overview
- 12.11.3 Zymo Research Corporation Revenue in Methylation Analysis Business (2021-2026)
- 12.11.4 Zymo Research Corporation Methylation Analysis Product Portfolio
- 12.11.5 Zymo Research Corporation Recent Developments
- 12.12 Epigentek
- 12.12.1 Epigentek Company Information
- 12.12.2 Epigentek Business Overview
- 12.12.3 Epigentek Revenue in Methylation Analysis Business (2021-2026)
- 12.12.4 Epigentek Methylation Analysis Product Portfolio
- 12.12.5 Epigentek Recent Developments
- 12.13 Promega Corporation
- 12.13.1 Promega Corporation Company Information
- 12.13.2 Promega Corporation Business Overview
- 12.13.3 Promega Corporation Revenue in Methylation Analysis Business (2021-2026)
- 12.13.4 Promega Corporation Methylation Analysis Product Portfolio
- 12.13.5 Promega Corporation Recent Developments
- 12.14 CD Genomics
- 12.14.1 CD Genomics Company Information
- 12.14.2 CD Genomics Business Overview
- 12.14.3 CD Genomics Revenue in Methylation Analysis Business (2021-2026)
- 12.14.4 CD Genomics Methylation Analysis Product Portfolio
- 12.14.5 CD Genomics Recent Developments
- 12.15 BioCat GmbH
- 12.15.1 BioCat GmbH Company Information
- 12.15.2 BioCat GmbH Business Overview
- 12.15.3 BioCat GmbH Revenue in Methylation Analysis Business (2021-2026)
- 12.15.4 BioCat GmbH Methylation Analysis Product Portfolio
- 12.15.5 BioCat GmbH Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst